-65.7%
MRNA vs RVMD
+576.1%
-641.8%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RVMD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.2% | +5.2% | +5.3% |
| 7D | -1.1% | -3.0% | +1.9% | -0.4% |
| 30D | +126.1% | -0.7% | +126.8% | +126.2% |
| 3M | +190.0% | +36.5% | +153.5% | +169.9% |
| 6M | +157.2% | +104.6% | +52.6% | +113.6% |
| YTD | +388.2% | +155.8% | +232.4% | +277.3% |
| 1Y | +467.0% | +340.7% | +126.4% | +281.5% |
| 3Y | +36.1% | +519.9% | -483.8% | -19.8% |
| All | -65.7% | +576.1% | -641.8% | -84.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RVMD.
Daily Out/Under-Performance
Portfolio return minus RVMD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RVMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RVMD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling